Edap TMS SA cash flow statement FOCL

In fiscal 2025, which ended Dec 31, 2025, Edap TMS SA used $16.4 million of cash from operations.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

Line
FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
Operating
Depreciation and amortization
—
3
Operating cash flow
—
-16
Investing
Investing cash flow
—
-6
Financing
Debt issued
—
12
Debt repaid
—
3
Financing cash flow
—
9
Change in cash
Effect of exchange rate
—
3
Net change in cash
—
-11
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
FOCL (Nasdaq)
Fiscal year ends
December 31
Headquarters
69120 Vaulx En Velin, France
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1041934

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.